Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
XB-2203 by XBiotech for Clostridioides difficile Infections (Clostridium difficile Associated Disease): Likelihood of Approval
XB-2203 is under clinical development by XBiotech and currently in Phase I for Clostridioides difficile Infections (Clostridium difficile Associated Disease)....